Gordon K, Foley P, Krueger J, Pinter A, Reich K, Vender R, Vanvoorden V, Madden C, Peterson L, Blauvelt A. Efficacy and Safety of Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Results from BE READY, a 56-Week Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study with Randomized Withdrawal. J of Skin [Internet]. 2020 Oct. 27 [cited 2024 Jul. 3];4(6):s83. Available from: https://jofskin.org/33014/index.php/skin/article/view/1116